Financial Recovery Potential Following Endo International’s emergence from Chapter 11 bankruptcy as a private entity, there may be opportunities to provide tailored financial solutions or consulting services to support their ongoing operational restructuring and growth initiatives.

Innovation Expansion The launch of innovative products like the Spatial Computing Injection Simulator and branded treatments such as Xiaflex and tiopronin presents opportunities to engage with Endo’s R&D and marketing teams for technology and advertising support solutions.

Asset Divestment Opportunities Endo’s recent sale of assets to Knight Therapeutics indicates ongoing strategic restructuring, which could open avenues to offer asset management, valuation, or integration services to support future portfolio adjustments.

Market Engagement Strategies With active marketing efforts including TV commercials and branded campaigns, there is potential to assist in expanding Endo’s brand visibility, digital engagement, and customer outreach through marketing technology and content development services.

Growth and Funding Support Endo's securing of significant financing ($900M) highlights its growth ambitions, providing an opportunity to offer financial products, investment advisory, or growth strategy consulting to assist in capital deployment and expansion plans.